Back
PROCEPT BioRobotics Vs. Avidity Biosciences Industry Stock Comparison
Buy
74
PRCT
PROCEPT BioRobotics
Last Price:
99.07
Seasonality Move:
-5.16%
Sell
39
RNA
Avidity Biosciences
Last Price:
46.69
Seasonality Move:
33.04%
Buy
74
PROCEPT BioRobotics (PRCT)
is a Buy
Is PROCEPT BioRobotics a Buy, Sell or Hold?
- The current PROCEPT BioRobotics [PRCT] share price is $99.07. The Score for PRCT is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- PRCT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy, Sell or Hold?
- The current Avidity Biosciences [RNA] share price is $46.71. The Score for RNA is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- RNA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PRCT Stock Price Chart
What is PROCEPT BioRobotics's stock price today?
-
The PROCEPT BioRobotics share price today is $99.07
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PRCT is experiencing buying pressure, which is a positive indicator for future bullish movement.
RNA Stock Price Chart
What is Avidity Biosciences's stock price today?
-
The Avidity Biosciences share price today is $46.71
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNA is experiencing buying pressure, which is a positive indicator for future bullish movement.
PRCT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.39 | Buy |
| Relative Strength Index (14 RSI): | 69.41 | Buy |
| Chaikin Money Flow: | 663895 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (67.96 - 92.5) | Buy |
| Bollinger Bands (100): | (62.3 - 83.06) | Buy |
RNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.21 | Buy |
| Relative Strength Index (14 RSI): | 54.01 | Buy |
| Chaikin Money Flow: | 478392 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.93 - 47.73) | Buy |
| Bollinger Bands (100): | (41.07 - 46.53) | Buy |
PRCT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 95.17 | Buy |
| 20-day SMA: | 82.19 | Buy |
| 50-day SMA: | 79.43 | Buy |
| 200-day SMA: | 63.69 | Buy |
| 8-day EMA: | 94.12 | Buy |
| 20-day EMA: | 86.64 | Buy |
| 50-day EMA: | 79.95 | Buy |
| 200-day EMA: | 65.42 | Buy |
RNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.84 | Buy |
| 20-day SMA: | 45.91 | Buy |
| 50-day SMA: | 44.53 | Buy |
| 200-day SMA: | 33.31 | Buy |
| 8-day EMA: | 45.81 | Buy |
| 20-day EMA: | 45.52 | Buy |
| 50-day EMA: | 44.7 | Buy |
| 200-day EMA: | 34.96 | Buy |
PROCEPT BioRobotics Earnings Growth & PRCT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and an increase next year of $0.37 per share.
Avidity Biosciences Earnings Growth & RNA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and a decrease next year of $0.40 per share.
PROCEPT BioRobotics Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Avidity Biosciences Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||